Algernon Pharmaceuticals Inc (AGNPF)

[Money $hot]

Algernon's "DMT Stroke Consultant" Dr/Professor David Nutt (a London resident) will be at the largest gathering of global Psychedelics experts to date in London on May 11 2022. There will likely be zero mention of Algernon because Dr. Nutt will be there to represent Compass Pathways. Yet another opportunity missed by the clown team at Algernon.

https://www.benzinga.com/markets/cannabis/22/04/26886825/a-landmark-gathering-of-psychedelics-executives-and-scientists-arrives-in-london-on-may-11

Those expected to attend include representatives of the Beckley Foundation; Compass Pathways (NASDAQ:CMPS); David Nutt, professor of neuropsychopharmacology at Imperial College London and chair of Drug Science and Crispin Blunt, member of Parliament.

The symposium will also feature important figures from the U.S., like Rick Doblin, founder of MAPS and MindMed’s (NASDAQ:MNMD) CEO Rob Barrow, who is a member of Benzinga’s Psychedelics Advisory Board as is Prof. Nutt.

The symposium is expected to cement the UK’s position as an early leader in the development of a profitable industry around psychedelics science and healthcare.

One would think with all the delaying of the DMT Phase 1 clinical trial originally planned to start in Q4 2021, the clown team would've been jumping all over themselves to get in on the action in London.

E Board Photo

https://upload.wikimedia.org/wikipedia/commons/9/9c/Bozo%27s_Circus_1968.JPG

Just Nutts (pun intended)!

https://algernonpharmaceuticals.com/?s=David+nutt

M$